News & Press Releases: Breaking News

ISCT’s President-Elect talks new, innovative therapies on Bloomberg News

Monday, April 29, 2019  
Share |

ISCT’s President-Elect Dr. Bruce Levine sat down with Bloomberg News to talk about how innovative, approved CAR-T therapies retrain the body’s immune system as an effective weapon to fight cancer. He also discusses the complex process of getting these groundbreaking therapies to the patient and into the market.


 Listen to the recording here. (13:40)

 


© 2019 ISCT. All rights reserved. 
ISCT, and the ISCT logo are registered trademarks of the International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of the International Society for Cellular Therapy.

ISCT Privacy Policy